Purification of two astroglial growth factors from bovine brain  by Pettmann, B. et al.
Volume 189, number 1 FEBS 2865 September 1985 
~uri~~ation of two astrog~ia~ growth factors from bovine 
brain 
B. Pettmann, M. Weibel, M. Sensenbrenner and G. Labourdette+ 
Centre de Neurochimie du CNRS and +INSERM U44,S rue Blaise Pascal, 67084 Strasbourg Cedex, France 
Received 4 June 1985; revised version received 15 July 1985 
The astrogfial growth factor (AGF), which induces a characteristic morphological change in cultured rat 
astroglial cells and stimulates their proliferation, was purified to homogeneity from bovine brain. Two dif- 
ferent methods were used, the second one incl~ing hymn-~pharo~ afftnity chromato~aphy. AGF is 
actually cornposed of two factors, AGFI and AGF2, which both modify the mo~holo~ and stimulate 
the proliferation of the astroglial cells. Several data suggest hat the AGFs are similar or possibly identical 
to the fibroblast growth factors (FGFs) isolated from brain [(1984) Proc. Natl. Acad. Sci. USA 81,357-361; 
and 69636963. A specific antiserum against AGFs was raised in mouse. 
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1. INTRODUCTION 
The morphologic~ modification of cultured 
astroglial cells under the influence of brain soluble 
extracts was first reported in 1972 [3]. Later it was 
found that these extracts also elicited an increase in 
the level of the S-100 protein [4] as well as the 
glutamine synthetase activity [5] and stimulated 
the proliferation of the cultured astroblasts [6,7]. 
Partial purification of factors from brain active 
on the morphology or the proliferation of 
astroglial cells in culture has been reported by us 
[7] and by Barritault et al. (181, our observations), 
Lim and Miller [9] and Lemke and Brockes [ 101. 
Different denominations were given to these fac- 
tors: glial maturation factor and subsequently 
astroglial growth factor (AGF), brain derived 
growth factor (BDGF), glial maturation factor 
(GMF) and glial growth factor (GGF), respective- 
ly. The first three factors could be identical since 
they are acidic and their A4, values are not very dif- 
ferent: 20000 for AGF [7], 14000 for BDGF [8], 
23 000 and 13 000 for GMF [9,11]. GGF is a basic 
molecule with an M, of 31 Ooo [lo]. 
Here we describe two methods for large scale 
purification of AGF to apparent homogeneity and 
we bring evidence that there are actually two dif- 
ferent factors, AGFl and AGF2. 
2. MATERIALS AND METHODS 
2.1. Test of the AGF on the astroblast 
morphology 
Cultures of astroblasts were prepared from 
brain hemispheres of newborn Wistar rats [7]. 
Cells from one brain were seeded in 30 tissue 
culture Falcon petri dishes (35 mm diameter), in 
2 ml of culture medium. Chromatographic frac- 
tions to be tested were added to the medium on day 
5 or 6 after seeding. 
2.2. ‘25r-iododeoxyuridine (IdU. incorporation in 
astrobIasts 
Chromatographic fractions found to be active 
on astroblast morphology were pooled. Aliquots 
and 1 j&i IdU (5 Ci/mg) were then added to 
6-day-old cultures. After 24 h the dishes were 
rinsed 3 times with 0.9% NaCl. The cells were 
scraped with a rubber policeman and sedimented 
at 2000 x g for 10 min; the cell pellets were 
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counted in an LKB 1260 gamma counter. 
Preliminary experiments performed using either 
cell pellets prepared as described or cells lysed in 
water and precipitated with 10% trichloroacetic 
acid showed that these two preparations contained 
the same radioactivity. 
2.3. Production of mouse polyclonal antibodies 
1 ml of the Pro RPC active fractions (see section 
3) was mixed with 10~1 of a control mouse serum 
and lyophilized. The dried material was dissolved 
in 100 ~1 water and mixed with 100 ~1 of complete 
Freund’s adjuvant. This preparation was injected 
intraperitoneally into a 2-month-old Balb/c 
mouse. Three injections were performed every 
third week. 
2.4. Sodium dodecyi sulfate-polyacrylamide get 
electrophoresis (SDS-PAGE) and silver 
staining 
SDS-PAGE was performed according to Laem- 
mli [12]. Gels (140 x 160 x 0.75 mm) were com- 
posed of a separating gel containing 15% 
acrylamide and of a stacking gel containing 4% 
acrylamide. Gels were fixed for at least 60 min in 
12% trichloroacetic acid, 24% methanol and 
0.01% Coomassie blue R250. They were rinsed 
twice in 30% methanol for 30 min, and treated 
with 0.005% dithiothreitol 3 times for 15 min. 
Staining was achieved by treatment with 0.1% 
AgNO3 for 25 min, followed by washing with 3% 
Na2CO3 twice for 1 min, and development was 
performed with 3% Na2C03,0.03% formaldehyde 
for 5 min. Stained gels were kept in 3% Na2CO3. 
2.5. Electrophoretic transfer and immunoblotting 
To obtain very thin protein bands on the 
nitrocellulose paper after electrophoretic transfer, 
the SDS-PAGE was modified: the acrylamide con- 
centration was lowered to 10% and the elec- 
trophoresis was performed for 2 h at 400 V instead 
of 12 h at 120 V. 
The procedure of Towbin et al. [ 131 was used for 
the transfer of proteins from polyacrylamide gels 
to nitrocellulose paper. After transfer the 
nitrocellulose blots were cut into vertical strips and 
incubated overnight at 4°C in PBS containing 3% 
bovine serum albumin (BSA). The blot strips were 
then incubated for 2 h at room temperature with 
the mouse-antiserum to AGF diluted 1: 200 in PBS 
containing 3% BSA and 10% normal goat serum. 
The strips were then washed for 30 min with 5 
changes in PBS and incubated at room 
temperature for 2 h with horseradish-peroxidase 
coupled goat antimouse immunoglobulins diluted 
1: 1000. After 30 min washing in PBS (with 5 
changes), bound peroxidase was detected using 
180 pg 4-chloro-1 -naphthol per ml PBS containing 
0.01% H202. 
2.6. Amino acids determination 
Protein samples were hydrolyzed in 6 M HCl 
containing 2% phenol and 1% ,&mercaptoethanol 
for 24 h at 110°C in nitrogen atmosphere. Cysteine 
content was determined as cysteic acid after per- 
formic acid oxidation [14]. Tryptophan was deter- 
mined after hydrolysis in 3 M methanesulfonic 
acid containing 0.2% tryptamine [15]. 
3. RESULTS 
3.1. First method of purification 
3.1.1. Acidic extraction 
Bovine brains (120) obtained fresh from the 
slaughterhouse were transported on ice to the 
laboratory. All subsequent steps were carried out 
at 4°C. Blood clots and bloody meninges were 
removed. Brains were homogenized through a con- 
tinuous homogenizer. Then 2 vols of 35 mM citric 
acid containing 0.5 mM PMSF were added and 
thoroughly mixed to give a homogenous suspen- 
sion. This homogenate was centrifuged at 5000 x 
g for 12 min. Supernatants were pooled. Solutions 
of 2 M Tris and of 0.5 M EDTA in 2 M Tris were 
added to give a final concentration of 60 mM Tris 
and 10 mM EDTA. The pH, which was 4.3 in the 
initial supernatant, was brought to 7.8 with 10 N 
NaOH. 
3.1.2. Blue-Trisacryl M affinity chromatography 
(IBF, France) 
The extract (about 100 1) was applied to a 3.5 1 
column of Blue-Trisacryl (11 x 36 cm) previously 
equilibrated in 20 mM Tris-HCl, pH 7.5 (Tris- 
buffer). The column was washed with 10 1 Tris- 
buffer. Stepwise elution was performed successive- 
ly with 10 1 of 0.5 M NaCl in Tris-buffer and 10 1 
of 2 M NaCl in Tris-buffer. Activity on the mor- 
phology of astroblasts was found in about 6 1 of 
the last eluate. 
103 
Volume 189, number 1 FEBSLETTERS September 1985 
3.1.3. Acidic precipitation 
The solution was acidified to pH 2.5 by addition 
of 1 N HCl and incubated at 4°C for 2 h. The 
precipitate was removed by sedimentation at 5000 
x g for 30 min. The supernatant was diluted with 
one volume of water and its pH was brought to 6.4 
with 1 N NaOH. 
3.1.4. Hydroxyapatite-Ultrogel (HA) chromatog- 
raphy (IBF, France) 
The solution was applied to an HA column 
(3.5 X 20 cm) equilibrated with 5 mM sodium 
phosphate, pH 6.5. The column was washed with 
50 mM sodium phosphate pH 6.5, then with 
25 mM sodium phosphate, pH 9.0, and the activity 
was eluted with 200 mM sodium phosphate, pH 
9.0. 
3.15. Mono S chromatography (FPLC Pharma- 
cia) 
The active fraction from the HA column 
(300 ml) was diluted with 900 ml water and the pH 
was adjusted to 4.5. The solution was applied to a 
Mono S HR 1000 column at 6 mllmin. Stepwise 
elution was performed at 0.36 M and 0.46 M 
NaCl; the activity was eluted at 0.46 M NaCl in 
about 40 ml. 
3.1.6. Pro RPC reversed phase chromatography 
(FPLC Pharmacia) 
10 ml aliquots of the active fraction from the 
Mono S column were applied to a Pro RPC 
HR 5/10 column at 0.25 ml/min. Column was 
washed with 0.05% trifluoroacetic acid and eluted 
with a gradient of acetonitrile. Activity was found 
in 2 areas (fig.1). 
3.2. Second method of ~~rificati~~ 
In preliminary experiments we tried a heparin- 
affinity column which had been used for the 
purification of an endothelial cell derived growth 
factor [ 161. We found that the heparin column also 
binds the AGFs and therefore used this for our 
second method of purification. 
This method differs from the first method only 
by the omission of HA and Mono S columns and 
the use of a heparin-affinity column instead. It was 
found also that skipping the 0.5 M NaCl elution of 
the Blue-Trisacryl column and the acidification of 
the 2 M NaCl eluate from that column had no ef- 
fect on the final purification. 
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Fig.1. Reversed phase chromato~aphy on Pro RPC 
Pharmacia column of 10 ml from the Mono S active 
fraction. Activity on astroglial morphology was found in 
hatched areas. 
3.2.1. Heparin-Sepharose CLdB affinity chroma- 
tography (Pharmacia) 
The 2 M NaCl eluate from the Blue-Trisacryl 
column was diluted with 3 vols of water, its pH 
was adjusted to 7.0. The preparation was apphed 
to a 25 ml heparin-Seph~ose column (1.6 x 
12 cm) previously equilibrate with 0.6 M NaCl in 
10 mM Tris-HCl, pH 7.0. Stepwise elution was 
performed in the same buffer but at 1 M NaCl and 
2 M NaCl. Activity was found in both eluates 
(fig.2A). The factors were called AGFl and AGF2, 
respectively. 
3.2.2. Pro RPC reversed phase chromatography 
7 ml aliquots of the 2 active peaks were applied 
successively to the Pro RPC column. AGFl was 
eluted at 25olo acetonitrile (fig.2C), and AGF2 at 
20% acetonitrile (fig.2B). AGF2 was almost pure 
after the heparin-Sepharose chromatography but 
AGFl was still contaminated. However, after Pro 
RPC chromatography, in the area of the activity, 
the AGFl was also pure. 
Analysis by SDS-PAGE (fig.3) shows that 
AGFl is composed of two very close bands with an 
M, of 17 500 and AGF2 is homogenous with an MI 
of 18500. 
Purification of AGFs is summarized in table 1. 
The higher amount of AGFl necessary for half- 
maximal proliferation stimulation after the Pro 
RPC chromatography indicates that some inac- 
tivation of this factor occurs during the purifica- 
tion step. 
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Fig.2. Heparin-Sepharose affinity chromatography of 
the 2 M NaCl eluate from the Blue-Trisacryl column 
(A). Reversed phase chromatography on Pro RPC 
column of the 2 M NaCl eluate (B) and of the 1 M NaCl 
eluate (C) from heparin-Sepharose. Activity was found 
in hatched areas. 
The amino acid compositions of AGFl and 
AGE;! are distinct (table 2). 
Antiserum was raised in mouse by irnrnu~~t~on 
with a mixture of AGFl and AGF2 obtained with 
the first purification method. The mixture was 
used because at that time we thought that the two 
66 K- 
45 K-, 
24 K- 
. . . 
18.4 K-L 
14.3 K-c 
Fig.3. SDS-PAGE of AGFs after reversed phase 
chromatography. 
factors were microheterogenous forms of the same 
protein. The specificity of this antiserum was 
tested by ~munoblotting: AGFl and AGF2, 
isolated by the second method, were sub~tted 
separately to SDS-PAGE and then transferred to 
nitrocellulose. The antiserum was found to react 
with both factors (fig.4). It is specific since it did 
not react with a blot of the eluate from the Blue- 
Trisacryl column; however, with this fraction no 
reaction was seen at the level of the two factors 
probably because of their very low amount (not 
shown). 
4. DISCUSSION AND CONCLUSION 
Since our previous method of purification of the 
AGF from bovine brain published in 1980 171, we 
have tried to improve it and developed various pro- 
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Table 1 
Purification of AGFl and AGF2 (second method) 
Purification 
step 
Protein 
recovery 
(mg) 
l/2 maximal 
activity 
(ngiml) 
TotaP 
activity 
units 
Activity 
recovery 
(Q) 
Fold 
purifi- 
cation 
Acidic extract 3.5 x lo5 23 400 1.50 x 10’ 100 - 
Blue-Trisacryl 1.8 x 10“ 1920 9.4 x lo6 63 12 
Heparin peak 1 2.30 3.1 7.4 x 10’ 4.9 7500 
Heparin peak 2 
AGF2 1.49 0.47 3.2 x lo6 21 49800 
Pro RPC AGFl 0.77 5.7 1.4 x lo5 1 4100 
a One unit is defined as the amount of protein necessary to stimulate half-maximal IdU 
incorporation 
Table 2 
Amino acid composition of the AGFs 
Amino 
acid 
AGFla Brainb AcidicC AGF2d Brainb Basice 
HGFcv brain HGFfl brain 
FGF FGF 
Asx 
Thr 
Ser 
Glx 
Pro 
Gly 
Ala 
CYS 
Val 
Met 
Ile 
Leu 
Tyr 
Phe 
His 
LYS 
Arg 
Trp 
14.8 (15) 15 14 
9.7 (10) 9 9 
8.7 ( 9) 9 10 
15 (15) 18 16 
6.9 ( 7) 7 7 
13.7 (14) 14 14 
4.8 ( 5) 5 5 
4.4 ( 4) 4 
4.4 ( 4) 4 5 
0.9 ( 1) 1 1 
6.3 ( 6) 6 6 
20.8 (21) 19 19 
7.5 ( 8) 7 7 
7.2 ( 7) 7 7 
5.5 ( 6) 6 5 
14.2 (14) 13 13 
7.5 ( 8) 5 6 
0.8 ( 1) 1 
Total 155 
Mean deviation 6.0% 7.1% 
13.9 (14) 14 12 
5.5 ( 6) 5 4 
10.6 (11) 10 9 
12.2 (12) 14 11 
10.2 (10) 12 9 
16.7 (17) 18 16 
10 (10) 9 9 
6.2 ( 6) 5 
6.6 ( 7) 6 5 
1.8 ( 2) 3 2 
4.4 ( 4) 3 3 
14.8 (15) 13 12 
7.7 ( 8) 7 6 
8.6 ( 9) 8 7 
3.3 ( 3) 3 2 
15.6 (16) 14 14 
14.4 (14) 11 10 
1.08 ( 1) 1 
165 
14.9% 17.3% 
a Based on an Mr of 17500 
b Heparin-binding growth factors purified from brain by Lobb and Fett [18] 
’ From Thomas et al. [l] 
d Based on an M, of 18 500 
e Isolated by heparinSepharose chromatography by Gospodarowicz e al. [2] 
Mean deviation is the mean of the differences between our values and those 
from other authors, for every amino acid 
106 
Volume 189, number 1 FEBS LETTERS September 1985 
cedures. The two last procedures which allow 
purification to homogeneity are reported here. The 
first one gave a very low yield (l-2%) mainly due 
to the HA column which attached only about 10% 
of the activity, No more activity was attached in a 
second passage through a new HA column. This 
behaviour is not explained. The second method is 
a combination of the first one and of a method 
described by Shing et al. [16] using heparin-affinity 
chromatography for the purification of an en- 
dothelial cell growth factor. Since then, the 
heparin-affinity step has also been used by several 
other authors to purify growth factors from ner- 
vous tissues [2,17,18] or from other sources 
[18,19]. 
We determined that AGFl is acidic and has an 
isoelectric point of 5.5 and AGF2 is basic with an 
isoelectric point around 9.5. This observation add- 
ed to the quasi-identity of their molecular masses 
suggest that the other acidic factors active on glial 
ABF AGF 
2 I 
cells previously described [7,8,9,11] are of the 
same family or identical to AGFl. The GGF [lo] 
which is basic could be related to AGF2, however, 
the molecular masses are different. 
Fig.4. Immunoblot of the mouse AGFs antiserum after 
reaction with the two isolated factors. 
Comparison of the amino acid composition of 
AGFs with that of other growth factors isolated 
Fig.5. Astrogliai cultures from cerebral hemispheres of newborn rat grown in nutrient medium alone for 8 days (a), 
in the presence of 10 ng/mI AGFl from day 6 to 8 (b), in the presence of 10 ng/ml AGFZ from day 6 to 8 (c). Scale 
bar: 50pm. 
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from brain and affecting proliferation of various 
cell types (table 2) shows a high homology between 
AGFl, the acidic FGF purified by Thomas et al. 
[l], and the heparin-binding rowth factor (Y 
(HGFcr) from Lobb and Fett [18] which was also 
eluted at 1 M NaCl from heparin-Sepharose, Good 
homology is also found between AGF2 and the 
basic FGF from Gospodarowicz et al. [2] or the 
HGF,& from Lobb and Fett [ 181, both eluted at 
high salt molarity from heparin-Sepharose. 
Molecular masses of all these factors are very 
close. These different data suggest that there are 
two families of growth factors, or possibly only 
two growth factors in the brain which are able to 
stimulate the proliferation of a variety of cell 
types. 
The two AGFs modify the morphology of the 
astroglial cells but the effect is not identical (fig.5). 
The effects on the proliferation are similar, 
although AGF2 seems to be more active than 
AGFl. More extensive comparison of the effects 
elicited by the two factors on the astsoglial cells has 
now to be considered. 
The ~tiserum raised against AGFs might allow 
us to gain information about the possible 
physiological role of these growth factors. 
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